Page 466 - TBE_Book_V2_2019

Chapter 14: Prevention

49. Zent O, Plentz A, Schwarz TF, et al. TBE 57. Hainz U, Jenewein B, Asch E, Pfeiffer KP,
booster immunization according to the rapid Berger P, Grubeck- Loebenstein B.
immunization schedule: are 3-year booster Insufficient protection for healthy elderly
intervals really necessary? Vaccine. adults by tetanus and TBE vaccines.
2004;23:312-5. Vaccine. 2005;23:3232-5.

50. Loew-Baselli A, Poellabauer EM, Pavlova BG, et 58. Wanke K, von Braun A, Häberli L, et al.
al. Seropersistence of tick-borne encephalitis Immunogenicity and safety of tick-borne
antibodies, safety and booster response to encephalitis vaccination in healthy elderly
FSME-IMMUN 0.5 ml in adults aged 18-67 individuals. Paper presented at: ECCMID,
years. Hum Vaccin. 2009;5:551-6. 2012; London, UK.

51. Rendi-Wagner P, Kundi M, Zent O, et al. 59. Stiasny K, Aberle JH, Keller M, Grubeck-
Persistence of protective immunity following Loebenstein B, Heinz FX. Age affects
vaccination against tick-borne encephalitis— quantity but not quality of antibody
longer than expected? Vaccine. 2004;22:2743- responses after vaccination with an
9. inactivated flavivirus vaccine against tick-
borne encephalitis. PLoS One.
52. Rendi-Wagner P, Paulke-Korinek M, Kundi M, 2012;7:e34145.
Wiedermann U, Laaber B, Kollaritsch H.
Antibody persistence following booster 60. Aberle JH, Aberle SW, Kofler RM, Mandl CW.
vaccination against tick-borne encephalitis: 3- Humoral and cellular immune response to RNA
year post-booster follow-up. Vaccine. immunization with flavivirus replicons derived
2007;25:5097-101. from tick-borne encephalitis virus. J Virol.
2005;79:15107-13.
53. Beran J, Xie F, Zent O. Five year follow-up
after a first booster vaccination against tick- 61. Gomez I, Marx F, Saurwein-Teissl M, Gould EA,
borne encephalitis following different primary Grubeck- Loebenstein B. Characterization of
vaccination schedules demonstrates long- tick-borne encephalitis virus-specific human T
term antibody persistence and safety. lymphocyte responses by stimulation with
Vaccine. 2014;32:4275-80. structural TBEV proteins expressed in a
recombinant baculovirus. Viral Immunol.
54. Weinberger B, Keller M, Fischer KH, et al. 2003;16:407-14.
Decreased antibody titers and booster
responses in tick-borne encephalitis vaccinees 62. Garner-Spitzer E, Wagner A, Paulke-
aged 50-90 years. Vaccine. 2010;28:3511-5. Korinek M, et al. Tick-borne encephalitis
(TBE) and hepatitis B nonresponders
55. Lindblom P, Wilhelmsson P, Fryland L, et al. feature different immunologic
Factors determining immunological response mechanisms in response to TBE and
to vaccination against tick-borne encephalitis influenza vaccination with involvement
virus in older individuals. PLoS One. of regulatory T and B cells and IL-10. J
2014;9:e100860. Immunol. 2013;191:2426-36.
56. Jilkova E, Vejvalková P, Stiborová I, 63. Hopf S, Garner-Spitzer E, Hofer M, Kundi M,
Skorkovský J, Král V. Serological Wiedermann U. Comparable immune
response to tick-borne encephalitis responsiveness but increased reactogenicity
(TBE) vaccination in the elderly—results after subcutaneous versus intramuscular
from an observational study. Exp Opin administration of tick-borne encephalitis (TBE)
Biol Ther. 2009;9:797-803. vaccine. Vaccine. 2016;34:2027-34.

468
461